Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diminished fibrinolysis in diabetes mellitus and its implication for diabetic vascular disease.

Journal of cardiovascular risk - 1 Apr 1997

Panahloo A, Yudkin J S

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arteriosclerosis
Share to Diabetic Angiopathies
Share to Fibrinolysis
Share to Hypolipidemic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Plasminogen Activator Inhibitor 1

Share to Thrombosis

Share to Tissue Plasminogen Activator

Share to Vascular Diseases

Source

Identifiers

PMID: 9304490

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diminished fibrinolysis in diabetes mellitus and its implication for diabetic vascular disease.PMID 9304490Read ↗

[Fibrinolysis in dysfibrinogenemia].Semantic proximity Read ↗

Cardiovascular disease in type 2 diabetics: epidemiology, risk factors and therapeutic modalities.Semantic proximity Read ↗

Macrovascular disease in diabetes: current status.Semantic proximity Read ↗

Maturity onset diabetes of the young and fibrin-related thrombosis risk.Semantic proximity Read ↗

Effect of single nucleotide polymorphism in thrombin-activatable fibrinolysis inhibitor on the risk of diabetic macrovascular disease.Semantic proximity Read ↗

Bleeding related to disturbed fibrinolysis.Semantic proximity Read ↗

Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.Semantic proximity Read ↗

Hyperglycemia and Endothelial Dysfunction in Atherosclerosis: Lessons from Type 1 DiabetesSemantic proximity Read ↗

Diabetes, Endothelial Dysfunction, and Vascular Repair: What Should a Diabetologist Keep His Eye on?Semantic proximity Read ↗

BβArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes.Semantic proximity Read ↗

Hematological and Hemorheological Parameters of Blood Platelets as Biomarkers in Diabetes Mellitus Type 2. A Comprehensive ReviewSemantic proximity Read ↗

The plasminogen (fibrinolytic) system.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.